Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peptide T in HIV-Positive Individuals With Cognitive Impairment
NCT00000392Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Jan 1990
- Primary completion
- Aug 1996
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Peptide T in HIV-associated neurocognitive disorder (HAND), sponsored by National Institute of Mental Health. Started Jan 1990; status: completed.
02
Drugs
Peptide T
03
Conditions
HIV-associated neurocognitive disorder (HAND)
Beyond the preview
Go deeper on NCT00000392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000392.